Arabic Arabic English English French French German German
dark

Moderna announces additional investments to increase global supply for COVID-19 vaccine to up to 3 billion doses in 2022

Moderna, Inc.Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine,

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

How Are Hospitals Coping With Non-Covid Medical Emergencies?

Next Post

5 Challenges Health IT Teams Are Facing In 2021

Related Posts
Total
0
Share